Home › NDC Lookup › RxCUI directory › RxCUI 2384457

Cedazuridine 100 MG / decitabine 35 MG Oral Tablet — RxCUI 2384457

RxNorm drug concept · Semantic clinical drug
RxCUI 2384457 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2384457
Official nameCedazuridine 100 MG / decitabine 35 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)100 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Decitabine Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Decitabine targets myelodysplastic syndromes, or MDS — conditions where your bone marrow isn't producing enough healthy blood cells and instead makes abnormal ones. It works by hel...
  • What exactly is decitabine treating in my body?
  • Decitabine is given as an IV infusion at a clinic or infusion center — you won't be taking anything by mouth at home. Depending on which schedule your doctor chose, you'll either c...
  • How will I receive this medication, and how long will treatment last?
📖 Read our full Decitabine Injection guide →

🕸️ Concept Web — How Cedazuridine 100 MG / decitabine 35 MG Oral Tabl... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Cedazuridine 100 MG / decitabine 35 MG Oral Tablet RxCUI 2384457

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Cedazuridine 2384449
    • Decitabine 15657
    • Cedazuridine / decitabine 2384456
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Inqovi 2384459
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Cedazuridine / decitabine Oral Tablet 2384455
    • Cedazuridine / decitabine Oral Product 2384453
    • Cedazuridine / decitabine Pill 2384454
    • Cedazuridine / decitabine Oral Tablet [Inqovi] 2384461
    • Inqovi Oral Product 2384462
    • Inqovi Pill 2384463
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  5. Packs 2

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 18 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2384457 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
64842-0727-09 1 BLISTER PACK in 1 CARTON (64842-0727-9) / 5 TABLET, FILM... INQOVI Taiho Pharmaceutical Co., Ltd. 2020-08-25
Observed labelers: Taiho Pharmaceutical Co., Ltd. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.